vs
Side-by-side financial comparison of Anteris Technologies Global Corp. (AVR) and Hyperliquid Strategies Inc (PURR). Click either name above to swap in a different company.
Hyperliquid Strategies Inc is the larger business by last-quarter revenue ($500.0K vs $310.0K, roughly 1.6× Anteris Technologies Global Corp.). Anteris Technologies Global Corp. runs the higher net margin — -9420.0% vs -60892.6%, a 51472.6% gap on every dollar of revenue.
Anteris Technologies Global Corp is a medical technology firm specializing in innovative structural heart care solutions. It develops and commercializes bioprosthetic heart valves and transcatheter intervention products, serving healthcare providers across North America, Europe, and Asia-Pacific, with core focus on cardiac surgery and interventional cardiology segments.
AVR vs PURR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $310.0K | $500.0K |
| Net Profit | $-29.2M | $-304.5M |
| Gross Margin | 70.6% | — |
| Operating Margin | -9343.5% | -57509.2% |
| Net Margin | -9420.0% | -60892.6% |
| Revenue YoY | — | — |
| Net Profit YoY | — | — |
| EPS (diluted) | $-0.74 | $-7.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $310.0K | $500.0K | ||
| Q3 25 | $429.0K | — | ||
| Q2 25 | $618.0K | — | ||
| Q1 25 | $556.0K | — |
| Q4 25 | $-29.2M | $-304.5M | ||
| Q3 25 | $-22.2M | — | ||
| Q2 25 | $-20.8M | — | ||
| Q1 25 | $-21.9M | — |
| Q4 25 | 70.6% | — | ||
| Q3 25 | 71.3% | — | ||
| Q2 25 | 76.1% | — | ||
| Q1 25 | 62.8% | — |
| Q4 25 | -9343.5% | -57509.2% | ||
| Q3 25 | -5190.0% | — | ||
| Q2 25 | -3379.3% | — | ||
| Q1 25 | -3917.3% | — |
| Q4 25 | -9420.0% | -60892.6% | ||
| Q3 25 | -5185.1% | — | ||
| Q2 25 | -3371.2% | — | ||
| Q1 25 | -3932.4% | — |
| Q4 25 | $-0.74 | $-7.43 | ||
| Q3 25 | $-0.62 | — | ||
| Q2 25 | $-0.58 | — | ||
| Q1 25 | $-0.61 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $281.9M |
| Total DebtLower is stronger | $22.0K | — |
| Stockholders' EquityBook value | $-93.0K | $589.8M |
| Total Assets | $23.0M | $616.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $281.9M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $49.0M | — |
| Q4 25 | $22.0K | — | ||
| Q3 25 | $26.0K | — | ||
| Q2 25 | $30.0K | — | ||
| Q1 25 | $30.0K | — |
| Q4 25 | $-93.0K | $589.8M | ||
| Q3 25 | $3.7M | — | ||
| Q2 25 | $24.4M | — | ||
| Q1 25 | $43.3M | — |
| Q4 25 | $23.0M | $616.6M | ||
| Q3 25 | $19.1M | — | ||
| Q2 25 | $39.9M | — | ||
| Q1 25 | $58.8M | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.01× | — | ||
| Q2 25 | 0.00× | — | ||
| Q1 25 | 0.00× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.5M | — |
| Free Cash FlowOCF − Capex | $-18.9M | — |
| FCF MarginFCF / Revenue | -6104.5% | — |
| Capex IntensityCapex / Revenue | 128.1% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-79.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.5M | — | ||
| Q3 25 | $-18.3M | — | ||
| Q2 25 | $-19.5M | — | ||
| Q1 25 | $-21.5M | — |
| Q4 25 | $-18.9M | — | ||
| Q3 25 | $-19.0M | — | ||
| Q2 25 | $-20.1M | — | ||
| Q1 25 | $-21.7M | — |
| Q4 25 | -6104.5% | — | ||
| Q3 25 | -4434.5% | — | ||
| Q2 25 | -3247.9% | — | ||
| Q1 25 | -3909.5% | — |
| Q4 25 | 128.1% | — | ||
| Q3 25 | 180.0% | — | ||
| Q2 25 | 86.9% | — | ||
| Q1 25 | 44.6% | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
